Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3064559 | Journal of Neuroimmunology | 2011 | 6 Pages |
Abstract
Matrix metalloproteinase-9 (MMP-9) plays an important role in some neuroinflammatory diseases through the blood–brain barrier (BBB) disruption. To investigate the pathogenicity of MMP-9 in neuromyelitis optica (NMO), serum and CSF MMP-9 concentrations were measured in 13 NMO and 15 multiple sclerosis (MS) patients and 14 healthy controls, and correlated with clinical and laboratorial parameters. Serum MMP-9 concentrations were significantly higher in NMO than MS and controls, and correlated with EDSS score, CSF/serum albumin ratio, and CSF IL-8 concentrations. Our results indicate that MMP-9, promoted by elevated IL-8 activation, plays a crucial role in the pathogenesis of NMO through the BBB disruption.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Takafumi Hosokawa, Hideto Nakajima, Yoshimitsu Doi, Masakazu Sugino, Fumiharu Kimura, Toshiaki Hanafusa, Toshiyuki Takahashi,